✦ LIBER ✦

GS-98-438 a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B: 48 week results

✍ Scribed by S. Hadziyannis; N. Tassopolous; E. Heathcote; T.T. Chang; G. Kitis; T. Rizzetto; P. Marcellin; S.G. Lim; M. Wulfsohn; M. Wollman; J. Fry; C. Brosgart

Book ID: 118564921
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 139 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80005-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two year results from a double-blind, ra

Two year results from a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B

✍ S. Hadziyannis; N. Tassopoulos; J. Heathcote; T.T. Chang; G. Kitis; M. Rizetto; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB

GS-98-437 a double-blind, randomized, pl

GS-98-437 a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for the treatment of patients with HBeAg+ chronic hepatitis B infection: 48 week results: Patrick Marcellin, Hopital Beaujon, Clichy France; Ting-Tsung Chang, National Cheng Kung Univ Hospital, Tainan Taiwan; Seng Gee Lim, National University Hospital, Singapore Singapore; Myron J Tong, Huntington Memorial Hospital, Pasadena, CA; William Sievert, Monash Medical Centre, Clayton, Victoria Australia; Mitchell Shiffman, McGuire VAMC, Richmond, VA; Lennox Jeffers, University of Miami, Miami, FL; Zack Goodman, Armed Forces Institute of Pathology, Washington, DC; Jia Ma, Anant Jain, John Fry, Carol L Brosgart, Gilead Sciences, Foster City, CA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB